Ameriprise
BNTC icon

Ameriprise’s Benitec Biopharma BNTC Stock Holding History

Ameriprise’s Portfolio BNTC Stock Details BNTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.35M Buy
408,770
+128,043
+46% +$1.48M ﹤0.01% 2527
2025
Q4 		$3.78M Buy
280,727
+126,313
+82% +$1.75M ﹤0.01% 2626
2025
Q3 		$2.17M Buy
154,414
+44,489
+40% +$568K ﹤0.01% 2961
2025
Q2 		$1.29M Buy
109,925
+75,507
+219% +$1.06M ﹤0.01% 3159
2025
Q1 		$448K Sell
34,418
-1,058
-3% -$12.8K ﹤0.01% 3531
2024
Q4 		$448K Buy
35,476
+20,597
+138% +$222K ﹤0.01% 3562
2024
Q3 		$137K Buy
+14,879
New +$133K ﹤0.01% 3798

Other funds holding BNTC

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
IAM
Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Ameriprise's BNTC Position: Q1 2026 in Review

Ameriprise increased its Benitec Biopharma (BNTC) stake by 46% in Q1 2026, buying an estimated $1.48M and bringing the position to 408,770 shares worth $4.35M. The position accounts for ﹤0.01% of the portfolio, ranked #2527.

Ameriprise first reported a position in BNTC in Q3 2024 and has held it in 7 quarters since. 88 funds tracked by Wall St. Rank hold BNTC as of Q1 2026.

  • Ameriprise held 408,770 shares of Benitec Biopharma worth $4.35M as of Q1 2026.
  • Ameriprise bought 128,043 Benitec Biopharma shares in Q1 2026, an estimated $1.48M.
  • Benitec Biopharma made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #2527 holding.
  • Ameriprise first reported a position in Benitec Biopharma in Q3 2024 and has held it in 7 quarters since.
  • 88 funds tracked by Wall St. Rank held Benitec Biopharma as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.